Shunt infection.
Nakahara
Kuniaki
K
Shimizu
Satoru
S
D000367:Age Factors; D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002557:Cerebrospinal Fluid Shunts / Q000009:adverse effects*; D020099:Coated Materials, Biocompatible / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007239:Infections; D015203:Reproducibility of Results; D012307:Risk Factors
D000900:Anti-Bacterial Agents; D020099:Coated Materials, Biocompatible